Skip to main content
. 2019 Jul 22;9:10572. doi: 10.1038/s41598-019-46819-z

Figure 3.

Figure 3

Kaplan-Meier survival curve illustrating poor prognosis in patients with lower expression of PAXIP1 (median OS, 34.6 months vs. 43.3 months for low and high expressions respectively, HR 2.595, 95% CI 1.022–6.589, p = 0.045). Low and high immunoreactivity scores were 0–3 and 4–9, respectively.